SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9%
Fri, 6 Nov

SUN PHARMA has announced its results for the quarter ended September 2020. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-19*
3
Jun-20*
3
Sep-20*
QoQ ChangeYoY Change
Net SalesRs m81,23475,85385,53112.8%5.3%
Other incomeRs m2,0091,5382,55866.3%27.3%
TurnoverRs m83,24277,39088,08913.8%5.8%
ExpensesRs m63,33657,41763,59910.8%0.4%
Gross profitRs m17,897-17,89821,93322.5%
DepreciationRs m4,7334,9594,9860.5%5.3%
InterestRs m839520333-35.9%-60.3%
Profit before taxRs m14,334-21,83919,17233.8%
TaxRs m2,6602,459-312-112.7%-111.7%
Profit after taxRs m11,674-24,29819,48466.9%
Gross profit margin%22.0-23.625.6
Effective tax rate%18.6-11.3-1.6
Net profit margin%14.0-31.422.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 5.3% on a year-on-year (YoY) basis. The expenses were up by 0.4% YoY during the same period.
  • The company's operating profit increased by 22.5% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 25.6% in 2QFY21 as against 22.0% in 2QFY20.
  • Depreciation charges increased by 5.3% and finance costs declined by 60.3% YoY, respectively.
  • Other income increased by 27.3% YoY during the quarter.
  • Net profit for the quarter increased by 66.9% YoY. Net profit margins during the quarter increased from 14.0% in 2QFY20 to 22.1% in 2QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 12.8% on a quarter-on-quarter (QoQ) basis. The expenses were up by 10.8% QoQ during the same period.
  • The company's operating profit declined by 222.5% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 25.6% in 2QFY21 as against 23.6% in 1QFY20.
  • Net profit for the quarter increased by 180.2% QoQ, while net profit margins increased from -31.4% in 1QFY20 to 22.1% in 2QFY21.

To see how SUN PHARMA has performed over the last eight quarters,please visit here.

FREE Subscription: Join Our YouTube Channel Today

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 427.6 to Rs 510.7, registering a Gain of Rs 83.1 or around 19.4%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 19,704.0 (down 0.4%). Over the last one year it has moved up from 13,231.2 to 19,704.0, a gain of 6,473 points (up 48.9%).

Overall, the S&P BSE SENSEX is up 3.6% over the year.

Current Valuations

At the current price of Rs 510.7, the price to earnings (P/E) ratio of SUN PHARMA stands at 118.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.0 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Mar 1, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - SUVEN LIFE SCIENCES COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS